Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A iBio, Inc. Filed by: EcoR1 Capital, LLC

May 15, 2026 2:26 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 34,543,561 shares of Common Stock outstanding on February 9, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 34,543,561 shares of Common Stock outstanding on February 9, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 34,543,561 shares of Common Stock outstanding on February 9, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended December 31, 2025.


SCHEDULE 13G



EcoR1 Capital, LLC
Signature:/s/ Oleg Nodelman
Name/Title:Manager
Date:05/14/2026
Oleg Nodelman
Signature:/s/ Oleg Nodelman
Name/Title:Reporting person
Date:05/14/2026
EcoR1 Capital Fund Qualified, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:05/14/2026
Exhibit Information

EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

ATTACHMENTS / EXHIBITS

ex991.htm

Categories

SEC Filings